LEMNYRUS
Live / Registered — Registered (as of 22 Mar 2022)
What this means for you
Registered since 22 Mar 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90018487
- Registration number
- 6674889
- Mark type
- Stylized text
- Filed
- 24 Jun 2020
- Published for opposition
- 06 Jul 2021
- Registered
- 22 Mar 2022
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, infection and inflammatory diseases and disorders
Owner
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prosecution history
- 22 Mar 2022 — REGISTERED-PRINCIPAL REGISTER
- 11 Feb 2022 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 18 Jan 2022 — NOTICE OF ALLOWANCE CANCELLED
- 11 Feb 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Jan 2022 — TEAS DELETE 1(B) BASIS RECEIVED
- 31 Aug 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Jul 2021 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 22 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Jul 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Jul 2021 — PUBLISHED FOR OPPOSITION
- 16 Jun 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 May 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 May 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED